Home \ preclinical experimental research

Library

Registered on ClinicalTrials

The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)
The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)
The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)
The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)
The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods
The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods
The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure
The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure
The value of mitochondrial dysfunction in stabilization
The value of mitochondrial dysfunction in stabilization
The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)
The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)
The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)
The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)
The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods
The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods
The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure
The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure
The value of mitochondrial dysfunction in stabilization
The value of mitochondrial dysfunction in stabilization

Preclinical experimental studies

The effect of Mexidol on the level of neurogenesis markers in acute cerebrovascular disorders in the experiment

Authors:

A.V. Schulkin, I.V. Chernykh, Yu.V. Abalenikhina, M.V. Gatsanoga, O.A. Andryushin, N.A. Kruzhalov, E.N. Yakusheva

FGBOU in the Ryazan State Medical University named after Academician I.P. Pavlova "of the Ministry of Health of Russia, Ryazan, Russia

Place of publication:

Journal of neurology and psychiatry named after S.S. Korsakova
2025, vol. 125, No. 2, p. 107–112

Read more

The study of the influence of ethylmethylhydroxypyridine of succinate on the effectiveness of non -steroidal anti -inflammatory drugs with visceral and somatic pain in the experiment on mice and rats

Author:
Ivanova E.A., Vasilchuk A.G., Matyushkin A.I. , Voronina T.A.

FGBNU "Research Institute of Pharmacology named after V.V. Zakusova ”, Moscow, Russia

Read more

The role of oxidative stress in acute experimental hemorrhagic stroke and therapeutic effects of Mexidol

Authors:
Voronina T.A., Kraneva V.A., Zolotov N.N., Kotelnikova S.O., Valdman E.A.

FGBNU "Research Institute of Pharmacology named after V.V. Zakusova ”, Moscow, Russia

Read more

The influence of Mexidol on cerebral mitochondriogenesis at a young age and with aging

Authors:
Kirova Yu.I. 1*, Shakova F.M. 1*, Germanova E.L. 1*, Romanova G.A. 1*, Voronina T.A. 2*

1* FGBNU "Scientific Institute of General Pathology and Pathophysiology", Moscow, Russia;
2* FGBNU "Research Institute of Pharmacology named after V.V. Zakusova ”, Moscow, Russia

Read more

Heroprotective effects of ethylmethylhydroxypyridine of succinate in an experimental study

Author:
Voronina T.A.

FGBNU "Research Institute of Pharmacology named after V.V. Zakusova ”, Moscow, Russia

Read more

The effect of Mexidol on physical performance and lactate in the blood of rats in conditions of light desingronosis

Authors

GOSTYUKHINA A.A. , Zaitsev K.V. , Torchoshchina T.A. , Svetlik M.V.

Place of publication:

Journal of Neurology and Psychiatry, 11, 2018

Read more

The influence of Mexidol on the expression of the NRF2 transcription factor in the cortex of the large hemispheres of the brain with experimental ischemia

Authors:
Yakusheva E.N., Yamlnikov P.Yu., Chernykh I.V., Schulkin A.V.

FGBOU in the Ryazan State Medical University named after Acad. I.P. Pavlova "of the Ministry of Health of Russia, Ryazan, Russia

Place of publication:
Journal of Neurology and Psychiatry, 5, 2018

Read more

The influence of Mexidol on the expression of the factor induced by HIF-1α hypoxia in the cortex of the large hemispheres of the brain of rats with ischemia

Authors:
Yakusheva E.N., Yamlnikov P.Yu., Chernykh I.V., Schulkin A.V.

FGBOU in the Ryazan State Medical University named after Acad. I.P. Pavlova ", Ryazan, Russia

Read more

Geronto -informational analysis of the properties of the Mexidol molecule

Authors:
Gromova O.A. 1.2* , Torshin I.Yu. 2* , Fedotova L.E. 1*

1* FSBOU VO "Ivanovo State Medical Academy", Ivanovo;
2* FSBI "Federal Research Center" Informatics and Management "of the Russian Academy of Sciences, Moscow

Read more

Comparative chemoreactic analysis of Mexidol

Authors:
Torshin I.Yu. 1* , Gromova O.A. 2* , Sardaryan I.S. 3* , Fedotova L.E. 3*

1* FSBEI in the Moscow Physics and Technical Institute, Dolgoprudny, Russia;
2* FSBEI in the "Ivanovo State Medical Academy" of the Ministry of Health of Russia, Ivanovo, Russia;
3* Federal State Budgetary Institution “St. Petersburg State Pediatric University” of the Ministry of Health of Russia, St. Petersburg, Russia

Read more

The distribution of Mexidol in the structures of the brain, its cellular elements and subcellular fractions

Authors:
Schulkin A.V., Yakusheva E.N., Chernykh I.V.

Ryazan State Medical University named after Academician I.P. Pavlova

Read more

Mexidol and hepatitis: the results in the experiment and prospects in the clinic

Author:
Farashchuk N.F.

GOU VPO Smolensk State Medical Academy

Read more

Features and mechanism of the neuroprotective action of Mexidol with hemorrhagic stroke in the experiment

Author:
Kraneva V.A.

GU Nii Pharmacology named after V.V. Zakusov RAMS, Moscow

Read more

THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.

Source of photos and images Shutterstock.com